Get the Stockscreener App
27.49
1.01%
-0.28
After Hours:
27.48
-0.010
-0.04%
Lakefront Biotherapeutics Nv Adr stock is traded at $27.49, with a volume of 123.62K.
It is down -1.01% in the last 24 hours and up +0.00% over the past month.
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.
See More
Previous Close:
$27.77
Open:
$27.7
24h Volume:
123.62K
Relative Volume:
4.49
Market Cap:
$1.81B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+1.63%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$27.44
$27.99
1-Week Range:
$26.42
$27.99
52-Week Range:
$26.42
$28.32
Lakefront Biotherapeutics Nv Adr Stock (LKFT) Company Profile
Name
Lakefront Biotherapeutics Nv Adr
Sector
Industry
Phone
-
Address
-
Compare LKFT vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LKFT
Lakefront Biotherapeutics Nv Adr
|
27.49 | 1.83B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.03B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
638.88 | 67.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
806.46 | 50.76B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
297.45 | 40.12B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
151.56 | 32.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Lakefront Biotherapeutics Nv Adr Stock (LKFT) Latest News
LKFT Technical Analysis | Trend, Signals & Chart Patterns | LAKEFRONT BIOTHERAPEUTIC-ADR (NASDAQ:LKFT) - ChartMill
LKFT.AS Stock Price, Quote & Chart | LAKEFRONT BIOTHERAPEUTICS (AMS:LKFT) - ChartMill
LKFT Stock Chart | LAKEFRONT BIOTHERAPEUTIC-ADR (NASDAQ:LKFT) - ChartMill
What is the current Price Target and Forecast for Lakefront BiotherapeuticsSponsored ADR (LKFT) - Zacks Investment Research
Earnings call transcript: Galapagos NV sees 91% revenue drop in Q1 2026 - Investing.com
LKFT: Lakefront BiotherapeuticsSponsored ADRCash Flow Statements - Zacks Investment Research
LKFT : Lakefront BiotherapeuticsSponsored Adr Key Company Details - Zacks Investment Research
Lakefront BiotherapeuticsSponsored ADR (LKFT) Return On Equity (TTM) - Zacks Investment Research
Lakefront Biotherapeutics NV Stock Baskets - GuruFocus
Lakefront Biotherapeutics (NASDAQ: GLPG) outlines ADR deposit terms - Stock Titan
LKFT Stock Price and Chart — NASDAQ:LKFT - TradingView
Earnings call transcript: Galapagos Q1 2026 beats EPS, revenue falls short - Investing.com
Galapagos (GLPG) posts Q1 2026 profit and commits up to €790M to Ouro deal - Stock Titan
Invesco Nasdaq Biotechnology ETF Holdings - Quiver Quantitative
symbol__ Stock Quote Price and Forecast - CNN
ActivePassive International Equity ETF Holdings - Quiver Quantitative
Lakefront Biotherapeutics Nv Adr Stock (LKFT) Financials Data
There is no financial data for Lakefront Biotherapeutics Nv Adr (LKFT). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
2.98%
1.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):